American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry
2000; 157: 49.
Elkin, I, Shea, MT, Watkins, JT, Imber, SD, Sotsky, SM, Collins, JF, Glass, DR, Pilkonis, PA, Leber, WR, Docherty, JP.
National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Arch Gen Psychiatry
1989; 46: 971–82.
Hollon, SD, Jarrett, RB, Nierenberg, AA, Thase, ME, Trivedi, M, Rush, AJ.
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
J Clin Psychiatry
2005; 66: 455–68.
Hardy, GE, Barkham, M, Shapiro, DA, Stiles, WB, Rees, A, Reynolds, S.
Impact of Cluster C personality disorders on outcomes of contrasting brief psychotherapies for depression. J Consult Clin Psychol
1995; 63: 997–1004.
Kool, S, Schoevers, R, de Maat, S, Van, R, Molenaar, P, Vink, A, Dekker, J.
Efficacy of pharmacotherapy in depressed patients with and without personality disorders: A systematic review and meta-analysis. J Affect Disord
2005; 88: 269–78.
Newton-Howes, G, Tyrer, P, Johnson, T.
Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry
2006; 188: 13–20.
DeRubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, O'Reardon, JP, Lovett, ML, Gladis, MM, Brown, LL, Gallop, R.
Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry
2005; 62: 409–16.
Hollon, SD, DeRubeis, RJ, Shelton, RC, Amsterdam, JD, Salomon, RM, O'Reardon, JP, Lovett, ML, Young, PR, Haman, KL, Freeman, BB, Gallop, R.
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry
2005; 62: 417–22.
First, M, Spitzer, R, Gibbon, M, Williams, J.
Structured Clinical Interview for DSM–IV–TR – Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID–I/P W/PSY SCREEN). Biometrics Research, New York State Psychiatric Institute, 2001.
A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Spitzer, R, Williams, J, Gibbon, M, First, M.
Structured Clinical Interview for DSM–II–R Personality Disorders (SCID–II, Version 1.0). American Psychiatric Press, 1990.
Doyle, TJ, Tsuang, MT, Lyons, MJ.
Comorbidity of depressive illnesses and personality disorders. In Comorbidity in Affective Disorders (ed Tohen, M): 105–156. Marcel Dekker Inc., 1999.
Keller, MB, Lavori, PW, Friedman, B, Nielsen, E, Endicott, J, McDonald-Scott, P, Andreasen, NC.
The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry
1987; 44: 540–8.
Kuritz, S, Landis, J, Koch, G.
A General overview of Mantel-Haenszel methods: applications and recent developments. Ann Rev Public Health
1988; 9: 123–60.
Hosmer, D, Lemeshow, S.
Applied Logistic Regression. Wiley, 1989.
Bryk, A, Raudenbush, S.
Hierarchical Linear Modeling: Applications and Data Analysis Methods. Sage, 1996.
Models in Educational and Social Research. Oxford University Press, 1987.
Measuring change: What individual growth modeling buys you. In Change and Development: Issues of Theory, Method, and Application. The Jean Piaget Symposium Series (eds Amsel, E, Renninger, KA): 213
243. Lawrence Erlbaum Associates, 1997.
Cox, D, Oakes, D.
Analysis of Survival Data. Chapman & Hall, 1984.
Preventing hung juries about therapy studies. J Consult Clin Psychol
1996; 64: 81–7.
Tyrer, P, Seivewright, N, Ferguson, B, Murphy, S, Johnson, AL.
The Nottingham study of neurotic disorder. Effect of personality status on response to drug treatment, cognitive therapy and self-help over two years. Br J Psychiatry
1993; 162: 219–26.
Diggle, P, Kenward, MG.
Informative drop-out in longitudinal data analysis. Appl Stat
1994; 43: 49–93.
Gibbons, RD, Hedeker, D, Elkin, I, Waternaux, C, Kraemer, HC, Greenhouse, JB, Shea, MT, Imber, SD, Sotsky, SM, Watkins, JT.
Some conceptual and statistical issues in analysis of longitudinal psychiatric data: Application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry
1993; 50: 739–50.
Depression comorbid with anxiety or medical illness: The role of paroxetine. Int J Psychiatry Clin Pract
2001; 5: 3–10.
Johnson, PA, Hurley, RA, Benkelfat, C, Herpertz, SC, Taber, KH.
Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci
2003; 15: 397–402.
New, AS, Buchsbaum, MS, Hazlett, EA, Goodman, M, Koenigsberg, HW, Lo, J, Iskander, L, Newmark, R, Brand, J, O'Flynn, K, Siever, LI.
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology
2004; 176: 451–8.
Salzman, C, Wolfson, AN, Schatzberg, A, Looper, J, Henke, R, Albanese, M, Schwartz, J, Miyawaki, E.
Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol
1995; 15: 23–9.
Wolff, MC, Leander, D.
Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology
2002; 27: 421–9.